Lonza Group

Bewertungs-Analyse

Über das Unternehmen

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, develo

Trading-Daten

💵 Dividenden-Info

Ähnliche Aktien aus dem Sektor

Wo kann ich Lonza Group kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.